OSA’s BioPhotonics Congress: Biomedical Optics Congress Closes with Strong Attendance, Focus on the

11 April 2017

OSA’s BioPhotonics Congress: Biomedical Optics Congress Closes with Strong Attendance, Focus on the Latest Advancements in Clinical Biophotonics, Microscopy, Optical Tomography and Spectroscopy

HOLLYWOOD — The  OSA BioPhotonics Congress: Biomedical Optics concluded in Hollywood, Florida with over 400 attendees and a robust technical program covering the ever increasing role of optics in biology and medicine. Today’s optical technologies can be used for imaging and sensing everything from molecules to man. The OSA BioPhotonics Congress was comprised of four topical meetings highlighting the role of optics in detecting, diagnosing, and treating diseases such as cancer and neurological disease.

The expanded congress included comprehensive peer-reviewed technical sessions, an exhibition, events focused on career development for young investigators, technology commercialization and translation and ample opportunities to network. Research topics incorporated into the technical program included: Clinical and Translational Biophotonics; Microscopy, Histopathology, and Analytics; Optical Tomography and Spectroscopy; and Optics and the Brain.

Keynote Programming
The Joint Plenary Session featured six notable researchers in BioPhotonics:
  • Stephen A. Bopart, Beckman Institute for Advanced Science and technology, University of Illinois at Urbana-Champaign, USA, Stain-Free Slide-Free Multiphoton Histopathology of Carcinogenesis and Cancer
  • Eric R. Fossum, Thayer School of Engineering, Dartmouth University, USA, Quanta Image Sensor: Photon Counting with High Resolution and High Frame Rate
  • Irene Georgakoudi, School of Engineering, Tufts University, USA, Unraveling the Origins of Endogenous Optical Metabolic Changes
  • Nozomi Nishimura, Department of Biomedical Engineering, Cornell University, USA, Exploring the Natural Behaviors of Cells in the Wild with In Vivo Multiphoton Microscopy
  • Kandice Tanner, Laboratory of Cell Biology, Center for Cancer Research, National Institutes of Health, USA, Using Optical Tweezers to Probe the Role of Tissue Biophysics in Metastasis
  • Arjun G. Yodh, Department of Physics and Astronomy at the University of Pennsylvania, USA, Diffuse Optical Monitoring of Biomarkers in Brain and Breast
Highlighted Research
Researchers from around the world presented industry-leading technical peer-reviewed papers on topics including:
  • Diagnosing Breast Cancer Using Red Light — Researchers from Milan, Italy, reported on an advance in instrument development that increases the sensitivity of Optical Mammography by as much as 1000-fold, by eliminating a time-wasting pre-scan step. Thus, the new instrument is both more robust and cheaper.
  • New Optical Modules Could Improve Thyroid Cancer Screening — An international research team from the LUCA Project has developed a point of care device that could enable consistent and cost-effective screening for thyroid nodules. The technology improves data acquisition and builds on the current ultrasound standard with a ‘hybrid optics/US [ultrasound] probe.’
OSA’s BioPhotonics Congress provided attendees from around the world with the opportunity to network, present, learn and connect. The 2019 OSA BioPhotonics Congress will be held in Tucson, Arizona, from 1-5 April.

About The Optical Society
Founded in 1916, The Optical Society (OSA) is the leading professional organization for scientists, engineers, students and business leaders who fuel discoveries, shape real-life applications and accelerate achievements in the science of light. Through world-renowned publications, meetings and membership initiatives, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of optics and photonics experts. For more information, visit osa.org.

Media Contacts: